Skip to main content
PRFX
NASDAQ Life Sciences

PainReform's DeepSolar Launches Smart TDD Service Targeting $60B+ Solar M&A Market

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.699
Mkt Cap
$2.736M
52W Low
$0.611
52W High
$6.65
52W Position info
14% above low
Off High info
89% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

PRFX is trading near its 52-week low of $0.611 (14% above the low) on light trading volume (0.1× avg).

Summary

PainReform's DeepSolar unit launched Smart TDD, a new solar due diligence service targeting the $60B+ global solar asset M&A market, signaling a strategic expansion into a high-growth sector.


Key Events · Product Development and Regulatory · PRFX

  • New Solar Due Diligence Service Launched

    PainReform's DeepSolar business unit introduced Smart TDD, an advanced technical due diligence service for solar assets.

  • Targets Multi-Billion Dollar Market

    The Smart TDD service is designed to address the $60B+ global solar asset M&A market, as well as other lifecycle milestones for solar plants.

  • Enhanced Audit Capabilities

    Smart TDD offers complete data coverage, AI-driven diagnostics, actionable output, and rapid turnaround to improve assessment accuracy and speed.


Analysis · PRFX · Life Sciences

PainReform Ltd., through its DeepSolar unit, has introduced Smart TDD, a new technical due diligence service for the solar asset M&A market. This service aims to provide comprehensive, fast, and accurate assessments for solar assets, addressing current market inefficiencies. For a company with a small market capitalization, launching a service targeting a multi-billion dollar global market represents a significant strategic move to diversify revenue streams and capitalize on the growing solar sector. Investors should monitor the adoption and revenue generation from this new offering.

At the time of this filing, PRFX was trading at $0.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.7M. The 52-week trading range was $0.61 to $6.65. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PRFX - Latest Insights

PRFX
Jul 27, 2026, 8:47 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.11
Real-time Price: $1.04 info
Change: -$0.0633 (-6%) info
Market Cap: $3.255M info
PRFX
Jul 08, 2026, 8:45 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $1.04 info
Change: -$0.2668 (-20%) info
Market Cap: $3.255M info
PRFX
Jul 08, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.43
Real-time Price: $1.04 info
Change: -$0.3868 (-27%) info
Market Cap: $3.255M info
PRFX
Jun 29, 2026, 5:00 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $1.41
Real-time Price: $1.04 info
Change: -$0.3668 (-26%) info
Market Cap: $3.255M info
PRFX
Jun 25, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.58
Real-time Price: $1.04 info
Change: -$0.5368 (-34%) info
Market Cap: $3.255M info